Latest information
Management Policy/Role
We will support the international partnership and expansion of member companies, accelerate product creation and business development, and contribute to the promotion of industrialization in the field of regenerative medicine, for the purpose to achieve the FIRM’s objective. In addition, we will promote regulatory harmonization of Asian countries and regions together with the regulatory authorities in order to realize an Asian market comparable to those in North America and Europe.